External validity of the “all-comers” design: insights from the BIOSCIENCE trial.

Title : External validity of the all-comers design: insights from the BIOSCIENCE trial

Source : PubMed
ID : 27033859
Authors : Franzone A, Heg D, Räber L, Valgimigli M, Piccolo R, Zanchin T, Yamaji K, Stortecky S, Blöchlinger S, Hunziker L, Praz F, Jüni P, Windecker S, Pilgrim T
Year : 2016
Disease Category : Cardiovascular diseases
Focused Population : Not Specified
Priori/Posteriori : Posteriori
Single-study Generalibility? : Single
Score/Non-Score : Non-score
Tutorial/Method : NHANES_T2D
Compared general demographic and patient characteristics : Yes
Compared disease-specific clinical characteristics : Yes
Compared adverse events : No
Compared outcomes/treatment effect (including survival) : Yes
Trial participants vs. general population (from EHR, survey, a cohort, etc) : Yes
Real-world data sources : CARDIOBASE Bern PCI Registry in the same institution (Bern University Hospital)
Target Population Data Type Levels : Hospital